Abstract:By mimicking the catalytic domains of natural antioxidant enzymes, a de novo metal‐organic framework modified with polydopamine is fabricated. It not only possesses superoxide dismutase‐like nanozyme activities but also biologically upregulates two endogenous antioxidant enzymes (HO1 and SOD2) through STAT3 signaling, effectively scavenging excessive reactive oxygen species and thereby powerfully salvaging neurons from ischemic insult poststroke. Following stroke, oxidative stress induced by reactive oxygen species (ROS) aggravates neuronal damage and enlarges ischemic penumbra, which is devastating to stroke patients. Nanozyme‐based antioxidants are emerging to treat stroke through scavenging excessive ROS. However, most of nanozymes cannot efficiently scavenge ROS in neuronal cytosol and mitochondria, due to low‐uptake abilities of neurons and barriers of organelle membranes, significantly limiting nanozymes' neuroprotective effects. To overcome this limitation, a manganese‐organic framework modified with polydopamine (pDA‐MNOF), capable of not only mimicking catalytic activities of natural SOD2's catalytic domain but also upregulating two endogenous antioxidant enzymes in neurons is fabricated. With such a dual anti‐ROS effect, this nanozyme robustly decreases cellular ROS and effectively protects them from ROS‐induced injury. STAT‐3 signaling is found to play a vital role in pDA‐MNOF activating the two antioxidant enzymes, HO1 and SOD2. In vivo pDA‐MNOF treatment significantly improves the survival of middle cerebral artery occlusion (MCAo) mice by reducing infarct volume and more importantly, promotes animal behavioral recovery. Further, pDA‐MNOF activates vascular endothelial growth factor expression, a downstream target of STAT3 signaling, thus enhancing angiogenesis. Taken together, the biochemical, cell‐biological, and animal‐level behavioral data demonstrate the potentiality of pDA‐MNOF as a dual ROS‐scavenging agent for stroke treatment.

A Redox Modulatory Mn3 O4 Nanozyme with Multi-Enzyme Activity Provides Efficient Cytoprotection to Human Cells in a Parkinson's Disease Model

Redox Modulatory Mn3O4 Nanozyme with Multi-enzyme Activity Provides Efficient Cytoprotection to Human Cells in Parkinson’s Disease Model**

Multienzymatic Antioxidant Activity of Manganese-Based Nanoparticles for Protection against Oxidative Cell Damage

Self-Assembly of Multi-nanozymes to Mimic an Intracellular Antioxidant Defense System.

Polydopamine-Based Nanocomposite As a Biomimetic Antioxidant with a Variety of Enzymatic Activities for Parkinson's Disease.

Facet‐Dependent Biodegradable Mn 3 O 4 Nanoparticles for Ameliorating Parkinson's Disease

Tri-element nanozyme PtCuSe as an ingenious cascade catalytic machine for the amelioration of Parkinson's disease-like symptoms

Tri-element Nanozyme PtCuSe As an Ingenious Cascade Catalytic Machine for the Amelioration of Parkinson’s Disease-Like Symptoms

Coordinated Axial Ligand and d-π Conjugated Network Makes the Difference: Engineered 2D Mn-Based Antioxidase Mimic for Enhancing Stem Cell Protection

Multi-enzymatic Activities of Ultrasmall Ruthenium Oxide for Anti-Inflammation and Neuroprotection

Reactive Oxygen Species Scavenging by Hemin-Based Nanosheets Reduces Parkinson's Disease Symptoms in an Animal Model

A Bioinspired Manganese‐Organic Framework Ameliorates Ischemic Stroke through its Intrinsic Nanozyme Activity and Upregulating Endogenous Antioxidant Enzymes

Antioxidant and Prooxidant Nanozymes: From Cellular Redox Regulation to Next‐Generation Therapeutics

Multi-shell nanocomposites based multienzyme mimetics for efficient intracellular antioxidation

Redox Trimetallic Nanozyme with Neutral Environment Preference for Brain Injury

Bioactive Nanoenzyme Reverses Oxidative Damage and Endoplasmic Reticulum Stress in Neurons under Ischemic Stroke

Platinum nanozymes recover cellular ROS homeostasis in an oxidative stress-mediated disease model

A Curcumin-Decorated Nanozyme with ROS Scavenging and Anti-Inflammatory Properties for Neuroprotection

A Redox Modulatory Sod Mimetic Nanozyme Prevents The Formation of Cytotoxic Peroxynitrite And Improves Nitric Oxide Bioavailability in Human Endothelial Cells

Polymeric Nanozyme with SOD Activity Capable of Inhibiting Self- and Metal-Induced α-Synuclein Aggregation

Catalytic-Enhanced Lactoferrin-Functionalized Au-Bi2 Se3 Nanodots for Parkinson's Disease Therapy Via Reactive Oxygen Attenuation and Mitochondrial Protection.